Journals / Experimed / 2026 / Volume: 14 Issue: 1

Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept

Tungki Pratama Umar(Division of Surgery and Interventional Science, University College London)0000-0001-6975-8096
Journal
Experimed
Pages
—
Publication Date
2024-04-24
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With the use of AI and CRISPR-Cas13a's molecular precision, as well as AI's computational power, cancer treatments may be administered with unprecedented precision and adaptability in the future.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The promise of AI and CRISPR-Cas13a in cancer gene therapy is a harmony of development and hope.
📊
Key Findings & Data:The promise of AI and CRISPR-Cas13a in cancer gene therapy is a harmony of development and hope.
💡
Conclusion & Impact:With the use of AI and CRISPR-Cas13a's molecular precision, as well as AI's computational power, cancer treatments may be administered with unprecedented precision and adaptability in the future.
🔬Design:Letter to Editor
📍Scope:Comprehensive Sample
⚙️Variables:Artificial intelligence · Cancer · CRISPR

Abstract

The promise of AI and CRISPR-Cas13a in cancer gene therapy is a harmony of development and hope. With the use of AI and CRISPR-Cas13a's molecular precision, as well as AI's computational power, cancer treatments may be administered with unprecedented precision and adaptability in the future.

🔖

Cite This Article

Umar, T. P. (2024). Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept. Experimed, Volume: 14 Issue: 1. https://doi.org/10.26650/experimed.1404013

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Roma-Rodrigues C, Rivas-Garaa L, Baptista PV, Fernandes AR. Gene therapy in cancer treatment: why go nano? Pharmaceutics 2020; 12(3): 233. google scholar
  2. Rao K. CRISPR-Cas13 and its applications in human therapeutics. J High Sch Sci 2021; 5(4): 1-21. google scholar
  3. Granados-Riveron JT, Aquino-Jarquin G. CRISPR-Cas13 precision transcriptome engineering in cancer. Cancer Res 2018; 78(15): 4107-13. google scholar
  4. Gao J, Luo T, Lin N, Zhang S, Wang J. A new tool for CRISPR-Cas13a-based cancer gene therapy. Mol Ther Oncolytics 2020; 19: 79-92. google scholar